Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruimin Huang

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Analytical Chemistry|July 13, 2022
Information Entropy-Based Strategy for the Quantitative Evaluation of Extensive Hyperspectral Images to Better Unveil Spatial Heterogeneity in Mass Spectrometry ImagingWenyong Wu, Jinjun Hou, Zijia Zhang, et al.
Oncogene|February 29, 2020
MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeabilityYu Li, Huibiao Zhang, Lei Fan, et al.
Journal of Medicinal Chemistry|June 17, 2024
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast CancerWen-Jing Wang, Lixin Gao, Simei Wang, et al.
Nature Communications|October 30, 2020
Light-induced primary amines and o-nitrobenzyl alcohols cyclization as a versatile photoclick reaction for modular conjugationAn-Di Guo, Dan Wei, Hui-Jun Nie, et al.
Nature Chemical Biology|June 3, 2020
Selective N-glycan editing on living cell surfaces to probe glycoconjugate functionFeng Tang, Mang Zhou, Ken Qin, et al.
Theranostics|October 31, 2024
SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3/CCL2/IL-6 axis and is regulated by VEZF1Meiqian Li, Yangyan Cui, Qi Qi, et al.
Theranostics|September 28, 2022
<sup>18</sup>F-FDG PET as an imaging biomarker for the response to FGFR-targeted therapy of cancer cells via FGFR-initiated mTOR/HK2 axisYuchen Jiang, Qinghe Zeng, Qinghui Jiang, et al.
Bioorganic Chemistry|October 15, 2024
Discovery of a Potent, selective and orally bioavailable CDK9 degrader for targeting transcription regulation in Triple-Negative breast cancerHui-Jun Nie, Ben-Fu Li, Jingya Sun, et al.
Journal of Medicinal Chemistry|September 20, 2021
Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast CancerDan Wei, Hanlin Wang, Qinghe Zeng, et al.
Theranostics|June 29, 2026
CDK9 degrader induces BRCAness and sensitizes castration-resistant prostate cancer to PARP inhibitorJiaxuan Li, Jingya Sun, Weisong Tan, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Analytical Chemistry|July 13, 2022
Information Entropy-Based Strategy for the Quantitative Evaluation of Extensive Hyperspectral Images to Better Unveil Spatial Heterogeneity in Mass Spectrometry ImagingWenyong Wu, Jinjun Hou, Zijia Zhang, et al.
Oncogene|February 29, 2020
MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeabilityYu Li, Huibiao Zhang, Lei Fan, et al.
Journal of Medicinal Chemistry|June 17, 2024
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast CancerWen-Jing Wang, Lixin Gao, Simei Wang, et al.
Nature Communications|October 30, 2020
Light-induced primary amines and o-nitrobenzyl alcohols cyclization as a versatile photoclick reaction for modular conjugationAn-Di Guo, Dan Wei, Hui-Jun Nie, et al.
Nature Chemical Biology|June 3, 2020
Selective N-glycan editing on living cell surfaces to probe glycoconjugate functionFeng Tang, Mang Zhou, Ken Qin, et al.
Theranostics|October 31, 2024
SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3/CCL2/IL-6 axis and is regulated by VEZF1Meiqian Li, Yangyan Cui, Qi Qi, et al.
Theranostics|September 28, 2022
<sup>18</sup>F-FDG PET as an imaging biomarker for the response to FGFR-targeted therapy of cancer cells via FGFR-initiated mTOR/HK2 axisYuchen Jiang, Qinghe Zeng, Qinghui Jiang, et al.
Bioorganic Chemistry|October 15, 2024
Discovery of a Potent, selective and orally bioavailable CDK9 degrader for targeting transcription regulation in Triple-Negative breast cancerHui-Jun Nie, Ben-Fu Li, Jingya Sun, et al.
Journal of Medicinal Chemistry|September 20, 2021
Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast CancerDan Wei, Hanlin Wang, Qinghe Zeng, et al.
Theranostics|June 29, 2026
CDK9 degrader induces BRCAness and sensitizes castration-resistant prostate cancer to PARP inhibitorJiaxuan Li, Jingya Sun, Weisong Tan, et al.
Pageof 12